Ideas to action: independent research for global prosperity
Search
Filters:
Experts
Facet Toggle
Topics
Facet Toggle
Content Type
Facet Toggle
Time Frame
Facet Toggle
Blog Post
March 07, 2024
An extraordinary cascade of crises threatens Africa’s growth and economic stability. The incomplete economic recovery from the global pandemic, Russia’s invasion of Ukraine, food and fuel inflation, rising debt distress, and Israel’s ongoing war in Gaza have all aggravated geopolitical and geo-econo...
Blog Post
February 26, 2024
As policymakers and financiers set their priorities for 2024, we gathered a group of experts who've been working on pandemics and pandemic financing from a range of perspectives including epidemiology, economics, insurance, policy, and advocacy. The purpose of our event was to map out the next steps...
Blog Post
February 09, 2024
Standing at a crucial crossroads, Libya is a nation brimming with promise yet besieged by peril. Recent strides by the “6+6 Committee” in establishing election laws have sparked hope in a country long plagued by turmoil. This development, a product of concerted effort following a decade of instabili...
Blog Post
November 15, 2023
During the COVID-19 pandemic, whole genomic sequencing (WGS)-based surveillance played a key role in identifying variants of concern, investigating their spread and transmissibility, and facilitating the design and optimization of medical countermeasures, including diagnostic tools and vaccines. How...
Blog Post
September 14, 2023
COVID-19 is fading from public discussion, countries’ , and hopes for a safer and fairer future are being dashed by potentially watered-down political commitments. Yet people around the world continue to feel the impacts of COVID-19 every day, other infectious disease threats have not magically gone...
Blog Post
September 05, 2023
Today the Africa Centers for Disease Control’s (ACDC) Health Economics Programme (HEP) has published a new policy brief on the cost-effectiveness of two COVID-19 oral antivirals (COAVs), a nirmatrelvir/ritonavir combination, developed by Pfizer and sold under the name Paxlovid, and Molnupiravir, dev...
Blog Post
July 25, 2023
As the RST builds momentum and scores of countries seek its concessional loans and technical assistance, a new CGD paper, The Resilience and Sustainability Trust: Early Learning and Challenges from Costa Rica and Rwanda, provide early learning from the point of view of lower-income countries themsel...
Blog Post
July 24, 2023
The UK has much to learn from its performance during the COVID-19 pandemic as well as its extensive involvement in the 2014 West African Ebola outbreak. Important questions linger as to why the UK—a world-leader in public health, and a country in possession of a flourishing biological research secto...
Blog Post
June 20, 2023
The Biden administration’s efforts to provide attractive alternatives to Chinese finance in the developing world coincides with a period of pronounced financial stresses for these countries. After years of ready access to capital markets, coinciding with China’s rise as the dominant source of govern...